Contribution of the interleukin‐1β gene polymorphism in multiple system atrophy
- 22 July 2002
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 17 (4) , 808-811
- https://doi.org/10.1002/mds.10124
Abstract
We studied genetic polymorphisms in the promoter region at position ‐511 of the interleukin (IL) ‐1β gene (IL‐1B‐511) and at position ‐889 of the IL‐1α gene (IL‐1A‐889), in 111 Japanese patients with multiple system atrophy (MSA) and 160 controls. The distribution of IL‐1B‐511 was significantly different between MSA patients and controls, because of the under‐representation of patients with homozygotes for allele 2 (IL‐1B‐511*2), a high producer of IL‐1β. The frequency of IL‐1A‐889*2, a high secretor of IL‐1α, was also decreased in MSA patients. Our findings suggest that abnormal cytokine expression may be implicated in the pathogenesis of MSA. © 2002 Movement Disorder SocietyKeywords
This publication has 18 references indexed in Scilit:
- Influence of interleukin-1β gene polymorphism on age-at-onset of spinocerebellar ataxia 6 (SCA6) in Japanese patientsNeuroscience Letters, 2001
- Influence of interleukin-1β gene polymorphisms on age-at-onset of sporadic Parkinson's diseaseNeuroscience Letters, 2000
- Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature, 2000
- Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's diseaseNeurology, 1996
- Multiple system atrophyCurrent Opinion in Neurology, 1995
- Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patientsNeuroscience Letters, 1994
- Intrastriatal implantation of interleukin-1Journal of Neurosurgery, 1994
- A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitroEuropean Journal of Clinical Investigation, 1992
- Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)Journal of the Neurological Sciences, 1989
- Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.Proceedings of the National Academy of Sciences, 1989